首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 製藥 > 製藥企業 > 各國市場中藥品市售後的品牌行銷趨勢
產業/市場分類
製藥 (4823)
肥胖症治療 (44)
非專利藥 (129)
疫苗 (181)
神經疾病 (172)
骨頭疾病治療 (37)
動物用醫藥 (18)
處方藥 (156)
規章 (130)
感染疾病 (347)
精神病 (85)
製藥企業 (526)
糖尿病 (191)
癌症 (903)
藥物開發 (1458)
DDS (182)
OTC 非處方藥 (150)
市場調查報告書

各國市場中藥品市售後的品牌行銷趨勢

Post-Launch Brand Marketing in Select Affiliate Markets

出版商 Cutting Edge Information
出版日期 2007年01月 商品編碼 47316
內容資訊 英文 87 Slides
價格
本報告書已不再販售

本報告已在2011年12月09日停止出版。

目錄

Abstract

Introduction-Cutting Edge Information published this report to assist individuals and teams who seek guidance in the allocation of post-launch marketing resources for pharmaceutical and biotechnology brands in specific affiliate markets around the world.

The information contained in this report is gathered from brand managers and directors, marketing team members, and vice presidents of marketing at several different companies. These brands' examples - which address a range of competitive pressures, resource support situations, clinical proficiency, and commercial prospects - provide models for teams moving to post-launch with varying levels of resource support.

Uncover real-world brand budgets from the first three years on the market:

Explore marketing budgets for 8 brands throughout their first, second and third years of market availability.

The brands are marketed in the following markets:

  • Asia/Japan (two brands)
  • Australia (one brand)
  • Canada (one brand)
  • Mexico (one brand)
  • Philippines (one brand)
  • South Africa (one brand)
  • Sri Lanka (one brand)
Each easy-to-navigate brand profile walks you through annual spending in three critical areas of product management:
  • Promotional Mix
    • Detail Aids
    • Samples
    • Speaker programs
    • Journal ads
    • Medical publications
    • Medical education
    • Patient education programs
    • DTC ads
  • Decision Support
    • Market research
    • Competitive intelligence
  • Market Access
    • Pricing strategy and analysis
    • Pharmacoeconomics
    • Reimbursement

Companies Included in Report

Brand data were collected from the following pharmaceutical and biotechnology companies:

  • Biogen Idec
  • Ferring Pharmaceuticals
  • GlaxoSmithKline Team 1
  • GlaxoSmithKline Team 2
  • Panpharma
  • Popular Pharmaceuticals
  • Sanfer
  • Sanofi-Aventis

Table of Contents

Executive Summary

  • Introduction
  • Contributing Companies
  • Definitions: Time Segments
  • Definitions: Resource Categories
  • Definitions: Promotional Mix
  • Definitions: Decision Support
  • Definitions: Market Access

Section 1: Asia/Oceania

  • Brand 1: Sri Lanka, Infectious Diseases Product
  • Brand 2: Philippines, Infectious Diseases Product
  • Brand 3: Japan/Pan-Asia, Women' s Health Product
  • Brand 4: Australia, Respiratory Product
  • Brand 5: Japan/Pan-Asia, Cardiovascular Product

Section 2: Americas

  • Brand 6: Mexico, Cardiovascular Product
  • Brand 7: Canada, Central Nervous System Product

Section 3: Africa

  • Brand 8: South Africa, Cardiovascular Product
Back to Top